English MBA program coming to IDC

Arison School of business will offer students graduate degrees in either International Management or Entrepreneurship.

By LEAH GRANOF
December 29, 2006 04:32

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Israel will soon have a new MBA program in English, courtesy of the Interdisciplinary Center in Herzliya (IDC). The Arison School of business will open at the beginning of the 2007 fall semester and offer students graduate degrees in either International Management or Entrepreneurship. Both programs are fully accredited by the Israeli Council for Higher Education. Academics from schools in the US and Europe will teach the classes. IDC Herzliya's Raphael Recanati International School, which currently offers complete B.A. programs in English, will provide social and logistical support to the new business school.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS